Comprehensive Sickle Cell Center Composite:Basic & Translational Research Program
Comprehensive Sickle Cell Center Composite:Basic & Translational Research Program
批准号:
7821232
负责人:
DEREK A PERSONS
金额:
$75.29万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2012-02-29
中文摘要
描述(由申请人提供):
根据RFA-HL-06-008号文件,圣裘德综合镰刀细胞中心自豪地提出了其竞争性续签拨款申请,题为“综合镰刀细胞中心”。在过去的5年里,圣裘德儿童研究医院(SJCRH)建立了一流的综合镰状细胞中心,该中心开展尖端的基础和临床研究,提供最先进的临床护理和患者服务,并提供与镰状细胞病(SCD)相关的卓越教育和培训。作为NHLBI CSCC网络的一员,圣裘德经常是由综合镰刀细胞中心组成的,在批准的中心间网络项目中,圣裘德以出色的登记、参与和领导而脱颖而出。在即将到来的5年资助周期中,圣裘德将继续保持这一卓越的良好记录,但将扩大努力,将SCD翻译和患者服务成果研究包括在内,并将通过与田纳西大学(UT)在Diggs-Kraus镰刀细胞中心和UT癌症研究所新建立的合作,为SCD成人提供强有力的医疗护理和研究承诺。圣裘德综合镰刀细胞中心仍然致力于促进对疾病病理生理学的了解,改进医疗管理模式,并开发SCD的治疗方法。
英文摘要
DESCRIPTION (provided by applicant):
The St. Jude Comprehensive Sickle Cell Center proudly presents its competitive renewal grant application in response to RFA-HL-06-008 entitled, "Comprehensive Sickle Cell Centers". Over the past 5 years, St. Jude Children's Research Hospital (SJCRH) has established a premier Comprehensive Sickle Cell Center that conducts cutting-edge basic and clinical research, provides state-of-the art clinical care and patient services, and offers outstanding education and training related to sickle cell disease (SCD). As a member of the NHLBI CSCC network comprised often Comprehensive Sickle Cell Centers, St. Jude has distinguished itself with outstanding enrollment, participation, and leadership for approved inter-Center network projects. For the upcoming 5-year funding cycle, St. Jude will continue this strong track record of excellence, but will expand efforts to include SCD translational and patient services outcomes research, and also will offer a robust commitment to medical care and research for adults with SCD through newly established collaborations with the University of Tennessee (UT) at both the Diggs-Kraus Sickle Cell Center and the UT Cancer Institute. The St. Jude Comprehensive Sickle Cell Center remains committed to advancing understanding of disease pathophysiology, to improving medical management modalities, and to developing cures for SCD.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Improved renal perfusion measurement with a dual navigator-gated Q2TIPS fair technique.
使用双导航器门控 Q2TIPS fair 技术改进了肾灌注测量。
DOI:
10.1002/mrm.22532
发表时间:
2010
期刊:
Magnetic resonance in medicine
影响因子:
3.3
作者:
[Song,Ruitian, Loeffler,RalfB, Hillenbrand,ClaudiaM]
通讯作者:
Hillenbrand,ClaudiaM
QUIPSS II with window-sliding saturation sequence (Q2WISE).
具有窗口滑动饱和序列 (Q2WISE) 的 QUIPSS II。
DOI:
10.1002/mrm.23093
发表时间:
2012
期刊:
Magnetic resonance in medicine
影响因子:
3.3
作者:
[Song,Ruitian, Loeffler,RalfB, Hillenbrand,ClaudiaM]
通讯作者:
Hillenbrand,ClaudiaM
DOI:
10.1111/j.1365-2141.2009.07602.x
发表时间:
2009-05
期刊:
British journal of haematology
影响因子:
6.5
作者:
[Hankins J, Aygun B]
通讯作者:
Aygun B
Hemodynamic responses to visual stimulation in children with sickle cell anemia.
镰状细胞性贫血儿童对视觉刺激的血流动力学反应。
DOI:
10.1007/s11682-011-9133-4
发表时间:
2011
期刊:
Brain imaging and behavior
影响因子:
3.2
作者:
[Zou,Ping, Helton,KathleenJ, Smeltzer,Matthew, Li,Chin-Shang, Conklin,HeatherM, Gajjar,Amar, Wang,WinfredC, Ware,RussellE, Ogg,RobertJ]
通讯作者:
Ogg,RobertJ
DOI:
10.1002/jmri.22418
发表时间:
2011-01
期刊:
Journal of magnetic resonance imaging : JMRI
影响因子:
--
作者:
[Song R, Tipirneni A, Johnson P, Loeffler RB, Hillenbrand CM]
通讯作者:
Hillenbrand CM
共 9 条
Gene therapy of sickle cell disease through enhancement of fetal hemoglobin
-
批准号:7784214
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2010
-
负责人:DEREK A PERSONS
-
依托单位:
Hematopoietic stem cell gene therapy for sickle cell disease
-
批准号:7821229
-
项目类别:
-
资助金额:$30.43万
-
财政年份:2009
-
负责人:DEREK A PERSONS
-
依托单位:
Gamma Globin Gene Therapy Using In Vivo Selection
-
批准号:7538839
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2007
-
负责人:DEREK A PERSONS
-
依托单位:
CORE--VECTOR PRODUCTION
-
批准号:6967760
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2004
-
负责人:DEREK A PERSONS
-
依托单位:
Y-Globin Gene Therapy Using In Vivo Selection
-
批准号:7528437
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2003
-
负责人:DEREK A PERSONS
-
依托单位:
Selectable Gamma-Globin Lentiviral Vectors for SCD
-
批准号:6508640
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2002
-
负责人:DEREK A PERSONS
-
依托单位:
GAMMA GLOBIN VECTORS FOR TREATMENT OF HEMOGLOBINOPATHIES
-
批准号:6499112
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2000
-
负责人:DEREK A PERSONS
-
依托单位:
GAMMA GLOBIN VECTORS FOR TREATMENT OF HEMOGLOBINOPATHIES
-
批准号:6351442
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2000
-
负责人:DEREK A PERSONS
-
依托单位:
GAMMA GLOBIN VECTORS FOR TREATMENT OF HEMOGLOBINOPATHIES
-
批准号:6026997
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2000
-
负责人:DEREK A PERSONS
-
依托单位:
GAMMA GLOBIN VECTORS FOR TREATMENT OF HEMOGLOBINOPATHIES
-
批准号:6629108
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2000
-
负责人:DEREK A PERSONS
-
依托单位:
Gamma Globin Gene Therapy Using In Vivo Selection
-
批准号:7538830
-
项目类别:
-
资助金额:$33.75万
-
财政年份:--
-
负责人:DEREK A PERSONS
-
依托单位:
Gene therapy of sickle cell disease through enhancement of fetal hemoglobin
-
批准号:8381552
-
项目类别:
-
资助金额:$35.55万
-
财政年份:--
-
负责人:DEREK A PERSONS
-
依托单位:
Gamma Globin Gene Therapy Using In Vivo Selection
-
批准号:7538812
-
项目类别:
-
资助金额:$33.75万
-
财政年份:--
-
负责人:DEREK A PERSONS
-
依托单位:
Gene therapy of sickle cell disease through enhancement of fetal hemoglobin
-
批准号:8324607
-
项目类别:
-
资助金额:$34.81万
-
财政年份:--
-
负责人:DEREK A PERSONS
-
依托单位:
CORE--VECTOR PRODUCTION
-
批准号:7122110
-
项目类别:
-
资助金额:$21.63万
-
财政年份:--
-
负责人:DEREK A PERSONS
-
依托单位:
CORE--VECTOR PRODUCTION
-
批准号:7280443
-
项目类别:
-
资助金额:$22.28万
-
财政年份:--
-
负责人:DEREK A PERSONS
-
依托单位:
CORE--VECTOR PRODUCTION
-
批准号:7686253
-
项目类别:
-
资助金额:$21.85万
-
财政年份:--
-
负责人:DEREK A PERSONS
-
依托单位:
Gamma Globin Gene Therapy Using In Vivo Selection
-
批准号:7538821
-
项目类别:
-
资助金额:$33.75万
-
财政年份:--
-
负责人:DEREK A PERSONS
-
依托单位:
Gene therapy of sickle cell disease through enhancement of fetal hemoglobin
-
批准号:8716797
-
项目类别:
-
资助金额:$36.5万
-
财政年份:--
-
负责人:DEREK A PERSONS
-
依托单位:
CORE--VECTOR PRODUCTION
-
批准号:7487357
-
项目类别:
-
资助金额:$22.23万
-
财政年份:--
-
负责人:DEREK A PERSONS
-
依托单位:
国内基金
海外基金
拟南芥SICKLE调控应激颗粒和耐热性的分子机制
-
批准号:32370324
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:胡筑兵
-
依托单位: